NO2580226T3 - - Google Patents

Info

Publication number
NO2580226T3
NO2580226T3 NO11725217A NO11725217A NO2580226T3 NO 2580226 T3 NO2580226 T3 NO 2580226T3 NO 11725217 A NO11725217 A NO 11725217A NO 11725217 A NO11725217 A NO 11725217A NO 2580226 T3 NO2580226 T3 NO 2580226T3
Authority
NO
Norway
Application number
NO11725217A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2580226T3 publication Critical patent/NO2580226T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO11725217A 2010-06-11 2011-06-03 NO2580226T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants
EP11725217.1A EP2580226B1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
NO2580226T3 true NO2580226T3 (hr) 2018-04-28

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11725217A NO2580226T3 (hr) 2010-06-11 2011-06-03

Country Status (24)

Country Link
US (2) US9327020B2 (hr)
EP (3) EP2397484A1 (hr)
JP (2) JP6004586B2 (hr)
KR (1) KR101929973B1 (hr)
CN (1) CN103154013B (hr)
AU (1) AU2011262606B2 (hr)
BR (1) BR112012031440A2 (hr)
CA (1) CA2802023C (hr)
CY (1) CY1119704T1 (hr)
DK (1) DK2580226T3 (hr)
ES (1) ES2654156T3 (hr)
HR (1) HRP20171947T1 (hr)
HU (1) HUE035187T2 (hr)
IL (1) IL223570A (hr)
LT (1) LT2580226T (hr)
MX (1) MX342946B (hr)
NO (1) NO2580226T3 (hr)
PL (1) PL2580226T3 (hr)
PT (1) PT2580226T (hr)
RS (1) RS56690B1 (hr)
RU (1) RU2595717C2 (hr)
SI (1) SI2580226T1 (hr)
WO (1) WO2011155822A1 (hr)
ZA (1) ZA201209395B (hr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
PT3193923T (pt) 2014-07-24 2019-12-05 Litevax B V Adjuvantes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
EP0773781B1 (en) * 1994-08-04 2003-10-22 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
EP1792607B1 (en) * 2005-12-01 2008-10-01 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
BRPI1007325A2 (pt) * 2009-02-02 2019-09-24 Otsuka Pharma Co Ltd "baixo peso molecular de polissulfatados derivados de ácido hialurônico e medicamentos que contenham o mesmo."
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
JP2013528211A (ja) 2013-07-08
PL2580226T3 (pl) 2018-05-30
JP6004586B2 (ja) 2016-10-12
HRP20171947T1 (hr) 2018-02-23
HUE035187T2 (hu) 2018-05-02
LT2580226T (lt) 2018-02-26
AU2011262606B2 (en) 2016-10-27
WO2011155822A1 (en) 2011-12-15
KR101929973B1 (ko) 2018-12-18
ZA201209395B (en) 2014-05-28
RU2013100945A (ru) 2014-07-20
RU2595717C2 (ru) 2016-08-27
EP3312188A1 (en) 2018-04-25
CN103154013A (zh) 2013-06-12
CA2802023C (en) 2020-07-14
EP2397484A1 (en) 2011-12-21
EP2580226A1 (en) 2013-04-17
JP2016216471A (ja) 2016-12-22
RS56690B1 (sr) 2018-03-30
US20130273082A1 (en) 2013-10-17
CY1119704T1 (el) 2018-06-27
EP2580226B1 (en) 2017-11-29
ES2654156T3 (es) 2018-02-12
MX2012014422A (es) 2013-08-27
MX342946B (es) 2016-10-18
BR112012031440A2 (pt) 2017-04-18
CN103154013B (zh) 2017-03-15
PT2580226T (pt) 2018-01-05
CA2802023A1 (en) 2011-12-15
SI2580226T1 (en) 2018-04-30
AU2011262606A1 (en) 2013-01-10
DK2580226T3 (en) 2018-01-08
IL223570A (en) 2017-03-30
KR20130056273A (ko) 2013-05-29
US9327020B2 (en) 2016-05-03
US20170057987A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
BR112013008959A2 (hr)
BR112012031500A2 (hr)
BR112012029986A2 (hr)
BR112012030039A2 (hr)
BR112012028408A2 (hr)
BR112012026492A2 (hr)
BR112012027808A2 (hr)
BR112012024897A2 (hr)
BR112012025307A2 (hr)
BR112012019354A2 (hr)
BR112012002126A2 (hr)
BR112012026946A2 (hr)
BR112012017960A2 (hr)
BR112012025482A2 (hr)
BR112013006400A2 (hr)
BR112012031826A2 (hr)
BR112012028186A2 (hr)
BR112012025577A2 (hr)
BR112012023249A2 (hr)
BR112012016456A2 (hr)
BR112012027015A2 (hr)
BR112012025308A2 (hr)
BR112012024872A2 (hr)
BR112012023265A2 (hr)
BR112013010949A2 (hr)